Symrise has today announced a cash offer to the shareholders of Probi, a global biotics solutions company, focused on researching, manufacturing, and delivering biotics for supplements and functional food. Symrise is Probi’s largest shareholder and has been a shareholder since 2012. Through its active involvement, Symrise has deep knowledge and understanding of Probi, its operations, and the market it operates in. Symrise has a long-term belief in Probi since the company has a very attractive product offering that makes the health-enhancing benefits of probiotics available to people everywhere, and a fantastic global team. Symrise believes that there is great potential to elevate Probi to the next level under the Symrise group, as a key driver to Symrise’s focused strategy in health.

Probi to realize their investment at an attractive valuation. Symrise has been a long-term sharehold-er in Probi and has acted with a long-term perspective in the best interest of the Company, its teams and shareholders. Today’s offer to Probi’s shareholders reflects Symrise’s conviction that Probi would see its prospects enhanced in a private environment. We are pleased that the offer has re-ceived the full support from Probi’s two other largest shareholders. As a global leader in products supporting health, Symrise is ideally placed to leverage and capitalize on the strong foundation the Probi team has built. By joining forces, we will further strengthen our respective capabilities to serve the market with leading customized solutions, unlocking even greater value for customers globally.”

Further information about the offer including the offer press release that Symrise published today is available at: www.symrise.com/probi.